Literature DB >> 12634311

Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum.

Somboon Leungwattanakij1, Trinity J Bivalacqua, Mustafa F Usta, Dae-Yul Yang, Jae-Seog Hyun, Hunter C Champion, Asim B Abdel-Mageed, Wayne J G Hellstrom.   

Abstract

The etiologies of erectile dysfunction (ED) after nerve-sparing radical prostatectomy have not been clearly elucidated. The aim of this study was to evaluate the effects of cavernous nerve injury on cavernous fibrosis, and to consider measures to prevent irreversible damage to the cavernous tissues. Twenty male Sprague-Dawley rats constituted the study population. The animals were divided into 2 groups; group 1 consisted of sham-operated rats (n = 10), and group 2 consisted of rats that underwent incision of both cavernous nerves (n = 10). Three months later, all rats underwent intracavernous papaverine injection (300 and 600 mg), and intracorporal pressures were recorded. Transforming growth factor-beta(1) (TGF-beta(1)) messenger RNA (mRNA) expression from rat penile tissue was measured using reverse transcriptase-polymerase chain reaction. Hypoxia-inducible factor-1alpha (HIF-1alpha), TGF-beta(1), and collagen I and III protein expressions were determined by Western blot analysis and immunohistochemical staining. Erectile function as studied with intracavernosal papaverine injection and histological analysis of penile cross-sections at 3 months was similar in both groups. TGF-beta(1) mRNA expression, HIF-1alpha, TGF-beta(1), and collagen I and III protein expressions were significantly greater in the neurotomy group. Immunohistochemical staining for TGF-beta(1), HIF-1alpha, and collagen III were qualitatively more positive in the neurotomy group, whereas collagen I staining was similar. This study demonstrates an increase in TGF-beta(1), HIF-1alpha, and collagen III synthesis in rat cavernosal smooth musculature after cavernous neurotomies. In theory, cavernous fibrosis may be reduced by employing various vasoactive agents or interventions that increase oxygenation to the corporal tissues during the postoperative period.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634311     DOI: 10.1002/j.1939-4640.2003.tb02668.x

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  63 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

2.  Periprostatic implantation of neural differentiated mesenchymal stem cells restores cavernous nerve injury-mediated erectile dysfunction.

Authors:  Jia-Feng Fang; Chang-Chang Jia; Zong-Heng Zheng; Xiao-Long Ye; Bo Wei; Li-Jun Huang; Hong-Bo Wei
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

3.  Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction.

Authors:  Maarten Albersen; Thomas M Fandel; Haiyang Zhang; Lia Banie; Guiting Lin; Dirk De Ridder; Ching-Shwun Lin; Tom F Lue
Journal:  Eur Urol       Date:  2010-10-26       Impact factor: 20.096

4.  Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy.

Authors:  Arthur L Burnett
Journal:  Rev Urol       Date:  2006

5.  Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art.

Authors:  Tariq Al Shaiji; Trustin Domes; Gerald Brock
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

6.  Should penile rehabilitation become the norm following radical prostatectomy?

Authors:  Tariq Al Shaiji; Mb Chb; Gerald Brock
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

Review 7.  Penile shortening after radical prostatectomy and Peyronie's surgery.

Authors:  Jonas S Benson; Michael R Abern; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

8.  miR-210 promotes IPF fibroblast proliferation in response to hypoxia.

Authors:  Vidya Bodempudi; Polla Hergert; Karen Smith; Hong Xia; Jeremy Herrera; Mark Peterson; Wajahat Khalil; Judy Kahm; Peter B Bitterman; Craig A Henke
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-06-20       Impact factor: 5.464

Review 9.  Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities.

Authors:  Thiago Fernandes Negris Lima; Joshua Bitran; Fabio Stefano Frech; Ranjith Ramasamy
Journal:  Int J Impot Res       Date:  2020-11-17       Impact factor: 2.896

10.  Predictive factors for return of erectile function in robotic radical prostatectomy: case series from a single centre.

Authors:  F J Garcia; P D Violette; G B Brock; S E Pautler
Journal:  Int J Impot Res       Date:  2014-08-07       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.